Concepts (173)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fibromyalgia | 14 | 2018 | 24 | 5.960 |
Why?
|
| Pain | 10 | 2014 | 282 | 1.900 |
Why?
|
| Exercise | 6 | 2014 | 591 | 1.800 |
Why?
|
| Osteoarthritis | 6 | 2012 | 74 | 1.610 |
Why?
|
| Pain Measurement | 15 | 2019 | 364 | 1.510 |
Why?
|
| Exercise Therapy | 5 | 2018 | 229 | 1.480 |
Why?
|
| European Continental Ancestry Group | 7 | 2009 | 1131 | 1.340 |
Why?
|
| Middle Aged | 35 | 2019 | 10829 | 1.130 |
Why?
|
| African Americans | 7 | 2009 | 1373 | 1.110 |
Why?
|
| Arthroplasty, Replacement, Knee | 6 | 2019 | 84 | 1.090 |
Why?
|
| Treatment Outcome | 15 | 2019 | 3099 | 1.090 |
Why?
|
| Walking | 3 | 2016 | 177 | 1.030 |
Why?
|
| Depression | 6 | 2014 | 380 | 0.990 |
Why?
|
| Arthroplasty, Replacement | 4 | 2009 | 17 | 0.950 |
Why?
|
| Osteoarthritis, Knee | 5 | 2019 | 80 | 0.830 |
Why?
|
| Female | 32 | 2019 | 18164 | 0.820 |
Why?
|
| Adult | 21 | 2018 | 8420 | 0.810 |
Why?
|
| Pain Threshold | 3 | 2018 | 95 | 0.780 |
Why?
|
| Male | 29 | 2019 | 17807 | 0.750 |
Why?
|
| Humans | 38 | 2019 | 29093 | 0.730 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2017 | 33 | 0.690 |
Why?
|
| Osteoarthritis, Hip | 3 | 2009 | 15 | 0.680 |
Why?
|
| Motivation | 2 | 2010 | 102 | 0.640 |
Why?
|
| Connective Tissue Diseases | 1 | 2017 | 8 | 0.600 |
Why?
|
| Biological Therapy | 1 | 2017 | 20 | 0.590 |
Why?
|
| Autoimmune Diseases | 1 | 2017 | 50 | 0.590 |
Why?
|
| Exercise Test | 1 | 2016 | 194 | 0.550 |
Why?
|
| Veterans | 5 | 2015 | 50 | 0.530 |
Why?
|
| Metformin | 1 | 2015 | 19 | 0.530 |
Why?
|
| Activities of Daily Living | 2 | 2013 | 238 | 0.510 |
Why?
|
| Neuralgia | 1 | 2015 | 48 | 0.510 |
Why?
|
| Severity of Illness Index | 7 | 2018 | 863 | 0.500 |
Why?
|
| Aged | 17 | 2018 | 9487 | 0.500 |
Why?
|
| Health Status | 5 | 2018 | 368 | 0.480 |
Why?
|
| Analgesics, Opioid | 1 | 2016 | 239 | 0.480 |
Why?
|
| Postural Balance | 1 | 2016 | 160 | 0.480 |
Why?
|
| Cyclopropanes | 1 | 2013 | 19 | 0.470 |
Why?
|
| Serotonin Uptake Inhibitors | 1 | 2013 | 35 | 0.460 |
Why?
|
| Pesticides | 1 | 2016 | 189 | 0.460 |
Why?
|
| Depressive Disorder | 1 | 2013 | 74 | 0.460 |
Why?
|
| Occupational Exposure | 1 | 2016 | 224 | 0.450 |
Why?
|
| Emigrants and Immigrants | 1 | 2016 | 235 | 0.450 |
Why?
|
| Transients and Migrants | 1 | 2016 | 281 | 0.440 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2018 | 464 | 0.440 |
Why?
|
| Antirheumatic Agents | 2 | 2017 | 27 | 0.430 |
Why?
|
| Interviews as Topic | 2 | 2010 | 249 | 0.420 |
Why?
|
| Diabetes Mellitus | 1 | 2015 | 366 | 0.420 |
Why?
|
| Disability Evaluation | 5 | 2015 | 211 | 0.410 |
Why?
|
| Multicenter Studies as Topic | 2 | 2018 | 92 | 0.410 |
Why?
|
| Adaptation, Psychological | 3 | 2019 | 125 | 0.410 |
Why?
|
| Interleukin-8 | 1 | 2011 | 23 | 0.410 |
Why?
|
| Hispanic Americans | 2 | 2016 | 904 | 0.400 |
Why?
|
| Chemokine CCL2 | 1 | 2011 | 47 | 0.400 |
Why?
|
| Reflex | 1 | 2010 | 15 | 0.390 |
Why?
|
| Health Care Costs | 1 | 2012 | 108 | 0.390 |
Why?
|
| Obesity | 1 | 2018 | 1063 | 0.380 |
Why?
|
| Health Care Rationing | 1 | 2009 | 11 | 0.370 |
Why?
|
| Antidepressive Agents | 1 | 2009 | 70 | 0.350 |
Why?
|
| Analgesics | 3 | 2015 | 126 | 0.340 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2009 | 48 | 0.340 |
Why?
|
| Patient Compliance | 1 | 2010 | 208 | 0.330 |
Why?
|
| Patient Satisfaction | 3 | 2017 | 222 | 0.320 |
Why?
|
| Culture | 1 | 2008 | 38 | 0.320 |
Why?
|
| Arthroplasty | 1 | 2008 | 29 | 0.310 |
Why?
|
| Decision Making | 2 | 2007 | 180 | 0.300 |
Why?
|
| Physicians, Family | 1 | 2007 | 14 | 0.300 |
Why?
|
| Persian Gulf Syndrome | 1 | 2006 | 1 | 0.290 |
Why?
|
| Gulf War | 1 | 2006 | 1 | 0.290 |
Why?
|
| Quality of Life | 2 | 2017 | 816 | 0.290 |
Why?
|
| Patient Care Management | 1 | 2006 | 17 | 0.280 |
Why?
|
| Attitude to Health | 1 | 2007 | 148 | 0.280 |
Why?
|
| Musculoskeletal Diseases | 1 | 2005 | 36 | 0.260 |
Why?
|
| Young Adult | 5 | 2015 | 2402 | 0.250 |
Why?
|
| Time Factors | 4 | 2013 | 2001 | 0.250 |
Why?
|
| Cross-Sectional Studies | 6 | 2018 | 1356 | 0.240 |
Why?
|
| Clinical Competence | 1 | 2007 | 307 | 0.240 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 2108 | 0.240 |
Why?
|
| Ethnic Groups | 1 | 2006 | 440 | 0.230 |
Why?
|
| Self Care | 2 | 2015 | 137 | 0.220 |
Why?
|
| Faith Healing | 1 | 2002 | 2 | 0.220 |
Why?
|
| Adolescent | 3 | 2015 | 3254 | 0.200 |
Why?
|
| Chronic Disease | 3 | 2009 | 369 | 0.200 |
Why?
|
| Arthralgia | 2 | 2019 | 31 | 0.200 |
Why?
|
| Longitudinal Studies | 2 | 2016 | 720 | 0.200 |
Why?
|
| United States | 5 | 2018 | 3630 | 0.190 |
Why?
|
| Prospective Studies | 4 | 2010 | 2019 | 0.190 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2014 | 43 | 0.190 |
Why?
|
| Retrospective Studies | 3 | 2015 | 3111 | 0.180 |
Why?
|
| Pilot Projects | 2 | 2011 | 469 | 0.170 |
Why?
|
| Research Design | 2 | 2010 | 286 | 0.160 |
Why?
|
| Counseling | 2 | 2010 | 85 | 0.160 |
Why?
|
| Illness Behavior | 1 | 2018 | 2 | 0.160 |
Why?
|
| Comorbidity | 3 | 2014 | 540 | 0.160 |
Why?
|
| Spondylitis, Ankylosing | 1 | 2017 | 3 | 0.150 |
Why?
|
| Attention | 1 | 2018 | 83 | 0.150 |
Why?
|
| Self Efficacy | 1 | 2017 | 70 | 0.150 |
Why?
|
| Gout | 1 | 2017 | 14 | 0.150 |
Why?
|
| Vasculitis | 1 | 2017 | 23 | 0.150 |
Why?
|
| Arthritis, Psoriatic | 1 | 2017 | 25 | 0.150 |
Why?
|
| Patient Education as Topic | 1 | 2019 | 251 | 0.150 |
Why?
|
| Immunologic Factors | 1 | 2017 | 48 | 0.150 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2017 | 145 | 0.140 |
Why?
|
| Biological Products | 1 | 2017 | 66 | 0.140 |
Why?
|
| Off-Label Use | 1 | 2015 | 11 | 0.130 |
Why?
|
| Outpatients | 2 | 2005 | 49 | 0.130 |
Why?
|
| Antibodies, Monoclonal | 1 | 2017 | 196 | 0.130 |
Why?
|
| Multivariate Analysis | 2 | 2007 | 637 | 0.130 |
Why?
|
| Body Mass Index | 1 | 2018 | 865 | 0.130 |
Why?
|
| Hypoglycemic Agents | 1 | 2015 | 176 | 0.120 |
Why?
|
| Case-Control Studies | 1 | 2016 | 859 | 0.120 |
Why?
|
| Research | 1 | 2013 | 72 | 0.110 |
Why?
|
| Feasibility Studies | 1 | 2013 | 263 | 0.110 |
Why?
|
| Double-Blind Method | 1 | 2013 | 501 | 0.110 |
Why?
|
| Physical Therapy Modalities | 1 | 2012 | 60 | 0.110 |
Why?
|
| Insurance Claim Review | 1 | 2012 | 27 | 0.110 |
Why?
|
| North Carolina | 1 | 2016 | 1423 | 0.100 |
Why?
|
| Sural Nerve | 1 | 2010 | 21 | 0.100 |
Why?
|
| Electromyography | 1 | 2010 | 58 | 0.100 |
Why?
|
| Electric Stimulation | 1 | 2010 | 102 | 0.090 |
Why?
|
| Telephone | 1 | 2010 | 48 | 0.090 |
Why?
|
| Clinical Protocols | 1 | 2010 | 95 | 0.090 |
Why?
|
| Indiana | 1 | 2009 | 4 | 0.090 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 129 | 0.090 |
Why?
|
| Prejudice | 1 | 2009 | 45 | 0.090 |
Why?
|
| Guideline Adherence | 1 | 2010 | 110 | 0.090 |
Why?
|
| Linear Models | 1 | 2010 | 426 | 0.090 |
Why?
|
| Fear | 1 | 2009 | 44 | 0.090 |
Why?
|
| Decision Support Techniques | 1 | 2010 | 104 | 0.090 |
Why?
|
| Health Behavior | 1 | 2010 | 214 | 0.080 |
Why?
|
| Aromatase Inhibitors | 1 | 2007 | 7 | 0.080 |
Why?
|
| Epidemiologic Methods | 1 | 2007 | 24 | 0.080 |
Why?
|
| Muscular Diseases | 1 | 2007 | 19 | 0.080 |
Why?
|
| Joint Diseases | 1 | 2007 | 33 | 0.080 |
Why?
|
| Logistic Models | 1 | 2009 | 727 | 0.080 |
Why?
|
| Psychometrics | 1 | 2007 | 129 | 0.070 |
Why?
|
| Certification | 1 | 2007 | 24 | 0.070 |
Why?
|
| Fatigue | 1 | 2007 | 68 | 0.070 |
Why?
|
| Insurance, Major Medical | 1 | 2006 | 1 | 0.070 |
Why?
|
| Demography | 1 | 2006 | 104 | 0.070 |
Why?
|
| Referral and Consultation | 1 | 2007 | 113 | 0.070 |
Why?
|
| Health Surveys | 1 | 2006 | 191 | 0.070 |
Why?
|
| Kansas | 1 | 2005 | 1 | 0.070 |
Why?
|
| Mental Disorders | 1 | 2006 | 103 | 0.070 |
Why?
|
| Continental Population Groups | 1 | 2007 | 221 | 0.070 |
Why?
|
| Mental Health | 2 | 2018 | 104 | 0.070 |
Why?
|
| Afghan Campaign 2001- | 2 | 2015 | 12 | 0.060 |
Why?
|
| Predictive Value of Tests | 1 | 2006 | 787 | 0.060 |
Why?
|
| Incidence | 1 | 2006 | 1119 | 0.060 |
Why?
|
| Survival Rate | 1 | 2005 | 795 | 0.060 |
Why?
|
| Radiography | 1 | 2003 | 353 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2017 | 726 | 0.050 |
Why?
|
| Perception | 1 | 2002 | 92 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2007 | 666 | 0.050 |
Why?
|
| Prevalence | 1 | 2003 | 896 | 0.050 |
Why?
|
| Cohort Studies | 1 | 2003 | 1687 | 0.040 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2002 | 326 | 0.040 |
Why?
|
| Arthritis | 1 | 2019 | 37 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2017 | 31 | 0.040 |
Why?
|
| Factor Analysis, Statistical | 1 | 2017 | 70 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2017 | 91 | 0.040 |
Why?
|
| Risk Factors | 1 | 2005 | 3531 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2017 | 190 | 0.040 |
Why?
|
| Nursing Process | 1 | 2015 | 2 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2015 | 68 | 0.030 |
Why?
|
| Affective Symptoms | 1 | 2014 | 16 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2019 | 670 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 525 | 0.030 |
Why?
|
| Anxiety | 1 | 2014 | 159 | 0.030 |
Why?
|
| Monitoring, Ambulatory | 1 | 2010 | 8 | 0.020 |
Why?
|
| Autoimmunity | 1 | 2007 | 26 | 0.020 |
Why?
|
| Geriatric Assessment | 1 | 2010 | 355 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2007 | 436 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2007 | 3717 | 0.010 |
Why?
|